Integrating AAT into TF-CBT for Maltreated Youth: A Randomized Feasibility Trial
Project Number5R21HD091887-02
Contact PI/Project LeaderALLEN, BRIAN J
Awardee OrganizationPENNSYLVANIA STATE UNIV HERSHEY MED CTR
Description
Abstract Text
Abstract
The eventual goal of this line of research is to determine whether, and through what mechanisms, Animal-
Assisted Therapy (AAT) is beneficial for the treatment of maltreated youth. The current project is a feasibility
study to determine if larger clinical trials are warranted. The specific aims of the current study are (1) to
examine whether the integration of AAT into standard Trauma-Focused Cognitive-Behavioral Therapy (TF-
CBT) enhances treatment effectiveness, (2) to evaluate the tolerability and feasibility of AAT when integrated
into TF-CBT, and (3) to evaluate hypothesized mediational processes that may explain observed positive
effects for the integration of AAT. Maltreated youth may display myriad emotional and behavioral symptoms;
prominent among these is posttraumatic stress (PTS). TF-CBT is a well-established evidence-based treatment
for PTS and other symptoms subsequent to child maltreatment and, therefore, is a suitable intervention for this
trial. Sixty (60) maltreated youth (ages 6-17) displaying elevated PTS will be assigned to receive TF-CBT or
TF-CBT+AAT using a blocked randomization procedure. The TF-CBT protocol is the standard 12 90-minute
sessions typically used in research trials. Youth in the TF-CBT+AAT condition will receive the standard
protocol with a certified service dog present in the room for each session and the youth will be allowed to
interact with the dog during session. A pre-post design will be used to ascertain whether the addition of AAT
prompts greater PTS reduction as well as greater improvements in other outcomes, including internalizing
symptoms, externalizing symptoms, and emotion regulation. Outcome metrics include caregiver and youth-
reported objective measures, and respiratory sinus arrhythmia (RSA) assessed via an electrocardiogram
(ECG) during both a resting and stress reactivity paradigm. Feasibility metrics assessed include treatment
satisfaction, ability to implement the TF-CBT components with a dog in the room, treatment disrupting events
attributable to the dogs, and whether the dogs experienced significant stress as a result of their participation.
Stress experienced by the dog will be determined through RSA, salivary cortisol, and behavioral responses.
Two prominent hypotheses regarding the mechanism of effect for AAT will be examined. First, therapeutic
rapport will be assessed at multiple increments to determine whether the presence of the dog improved the
quality or efficiency of development of rapport. Second, RSA will be recorded for the youth during treatment
sessions to determine if the presence of the dog yielded a lower intensity of stress during the sessions. Both
therapeutic rapport and level of in-session stress will be examined as mediating variables to determine whether
either explained enhanced treatment outcomes. To improve the methodological rigor of the study, data will be
collected by research assistants blinded to the youth's treatment condition and the same clinicians will
implement both treatment conditions, thereby eliminating clinician-specific effects on outcomes.
Public Health Relevance Statement
Public Health Relevance
The proposed study will examine the incremental benefit of animal-assisted therapy (AAT) as an adjunct to the
implementation of Trauma-Focused Cognitive-Behavioral Therapy for the treatment of maltreated youth. In
addition, the development of therapeutic rapport and the intensity of stress experienced during treatment
sessions will be examined as mediating influences on treatment outcome. This study will help determine
whether AAT may improve treatment outcome for these youth as well as examine the mechanisms through
which it might impact outcome.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AgeAnimalsAnti-Anxiety AgentsAnxietyAppointments and SchedulesBehavioral SymptomsBlindedCanis familiarisCaregiversChildChild AbuseChild Abuse and NeglectClinical TrialsCognitive TherapyDataDevelopmentElectrocardiogramElementsEmotionsEventEvidence based treatmentFailureFeasibility StudiesFrequenciesGoalsHydrocortisoneInterventionIntervention TrialMeasuresMediatingMental DepressionMental HealthMethodologyOutcomeParticipantProblem behaviorProceduresProcessProtocols documentationPublicationsRandomizedRandomized Clinical TrialsRandomized Controlled TrialsReportingResearchResearch AssistantRestReview LiteratureSalivaryServicesSinus ArrhythmiaStressSurveysSymptomsTherapeuticTraumaTreatment EffectivenessTreatment outcomeYouthanimal-assisted therapybehavioral responsedesignemotion regulationemotional symptomexperiencefeasibility trialimprovedindexinginnovationmaltreated childrenpost-traumatic stresspublic health relevancerespiratoryretention ratesatisfactionstress reactivitystress reductionsymptomatologytherapeutic development
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
129348186
UEI
TNKGNDAWB445
Project Start Date
01-May-2017
Project End Date
30-April-2020
Budget Start Date
01-May-2018
Budget End Date
30-April-2020
Project Funding Information for 2018
Total Funding
$194,381
Direct Costs
$125,000
Indirect Costs
$69,381
Year
Funding IC
FY Total Cost by IC
2018
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$194,381
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21HD091887-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21HD091887-02
Patents
No Patents information available for 5R21HD091887-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21HD091887-02
Clinical Studies
No Clinical Studies information available for 5R21HD091887-02
News and More
Related News Releases
No news release information available for 5R21HD091887-02
History
No Historical information available for 5R21HD091887-02
Similar Projects
No Similar Projects information available for 5R21HD091887-02